Type I interferon-producing cells and uses thereof

Details Type I interferon-producing cells and uses thereof Type I interferon-producing cells and uses thereof

2007-02-20

2007-02-20

Kaushal, Sumesh (Department: 1633)

Drug, bio-affecting and body treating compositions

In vivo diagnosis or in vivo testing

C435S004000, C435S007100, C435S007200, C435S007210, C424S009200, C424S520000, C424S529000, C424S534000

Reexamination Certificate

active

10067146

ABSTRACT:
The present invention provides compositions for the treatment, inhibition or prevention of diseases or disorders, including cancer, immune diseases or disorders, and infectious diseases, comprising interferon-producing cells (IPCs) and methods of administering the IPCs. The present invention also provides compositions for the treatment, inhibition or prevention of diseases or disorders, including cancer, immune diseases or disorders, and infectious disease, comprising purified interferon (IFN) from IPCs and methods of administering the IFN. The present invention further provides methods for monitoring the progression of a disease or a disorder such as HIV infection or cancer, comprising measuring the abundance of IPCs in lymphoid organs or blood samples from a subject suffering from a disease or disorder.

REFERENCES:
patent: 5676942 (1997-10-01), Testa et al.
Shodell et al Scan. J. Immunol 56:518-521, 2002.
Schmidt et al. Variations in Plasmacytoid Dendritic Cell (PDC) and Myeloid Dendritic Cell (MDC) Levels in HIV-Infected Subjects on and off Antiretroviral Therapy. J Clin Immunol. 26(1):55-64, 2006.
Finke et al.Dendritic cell numbers in the blood of HIV-1 infected patients before and after changes in antiretroviral therapy. J Clin Immunol. 24(6):647-52, 2004.
Abb et al., 1983, “Phenotype of human alpha-interferon producing leucocytes identified by monoclonal antibodies,” Clin Exp Immunol. 52(1):179-84.
Autran et al., 1997, “Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease,” Science 277(5322):112-6.
Bandyopadhyay et al., 1986, “Requirement for HLA-DR+ accessory cells in natural killing of cytomegalovirus-infected fibroblasts,” J Exp Med. 164(1):180-95.
Brinkmann et al., 1993, “Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells,” J Exp Med. 178(5):1655-63.
Bubenik, 1996, “Cytokine Gene-Modified Vaccines in the Therapy of Cancer,” Pharmacol. Ther. 69(1):1-14.
Cederblad et al., 1991, “Interferons and the colony-stimulating factors IL-3 and GM-CSF enhance the IFN-alpha response in human blood leucocytes induced by herpes simplex virus,” Scand J Immunol. Nov. 1991;34(5):549-55.
Chehimi et al., 1989, “Dendritic cells and IFN-alpha-producing cells are two functionally distinct non-B, non-monocytic HLA-DR+ cell subsets in human peripheral blood,” Immunology 68(4):488-90.
Clerici et al., 1994, “The Th1-Th2 hypothesis of HIV infection: new insights,” Immunol Today 15(12):575-81 Review.
Dong et al., 1999, Cancer Res. 59:872-879.
Eck et al., 1996, “Gene-Based Therapy,” Pharmacological Basis of Therapeutics, Chapter 5: 77-101.
Empson et al., 1999, “Atopy, anergic status, and cytokine expression in HIV-infected subjects,” J Allergy Clin Immunol. 103(5 Pt 1):833-42.
Feldman et al., 1995, J. Leuk. Biol. 57:214-220.
Feldman et al., 1994, Virology 204:1-7.
Feldman et al., 1990, J. Interferon Res. 10:435-446.
Ferbas et al., 1995, Clin. Diagn. Lab. Immunol. 2:138-142.
Ferbas et al., 1994, J. Immunol. 152:4649-4662.
Fitzgerald-Bocarsly, 1993, Pharmacol. Ther. 60:39-62.
Fitzgerald-Bocarsly, 1988, J. Leuk. Biol. 43:323-334.
Ghanekar et al., 1996, J. Immunol. 157:4028-4036.
Grourard et al., 1997, J. Exp. Med. 185:1101-1111 (or Grouard).
Harrison et al., 1997, J.. Immunol. 158:459-463.
Howell et al., 1994, Clin. Immunol. Immunopathol. 71(2):223-230.
Isaacs et al.l, 1957, Proc. R. Soc. London 147:25B.
Kirchner et al., 1979, Immunobiology 156:65-75.
Komanduri et al., 1998, Nat. Med. 4:953-956.
Kostense et al., 1998, AIDS 12:F235-240.
Ledergerber et al., 1999, J. Amer. Med. Assn. 282:2220-2226.
Lederman et al., 1998, J. Inf. Dis. 178:70-79.
Ledley, 1991, Human Gene Therapy 2:77-83.
Leigh et al., 1998, J. Acquir. Immune Ded. Syndr. Hum. Retrovirol. 19:373-380.
Lopez et al., 1983, J. Inf. Dis. 148:962-966.
Marrack et al., 1999, J. Exp. Med. 189:52.
Milone et al., 1998, J. Immunol. 161:2391-2399.
Mocroft et al., 1998, Lancet 352:1725-1730.
O'Doherty et al., 1994, Immunology 82:487.
O'Doherty et al., 1993, J. Exp. Med. 178:1067.
Olweus et al., 1997, PNAS USA 94:125551.
Pakker et al., 1998, Nat. Med. 4:208-214.
Palella et al., 1998, N. Engl. J. Med. 338:853-860.
Parronchi et al., 1996, Eur. J. Immunol. 26:697-703.
Payvandi et al., 1998, J. Immunol. 160:5861-5868.
Perussia et al., 1985, Nat. Immunol. Cell Growth Regul. 4:120-137.
Peter et al., 1980, Eur. J. Immunol. 10:547-555.
Pontesilli et al., 1999, Immunol. Lett. 66:213-217.
Powderly et al., 1998, J. Amer. Med. Assoc. 280:72-77.
Qin et al., 1998, PNAS 95:14411-14416.
Rappocciolo et al., 1989, J. Clin. Microbiol. 27:41-48.
Rissoan et al., 1999, science 283:1183-1186.
Rogge et al., 1998, J. Immunol. 161:6567-6574.
Sandberg et al., 1991, Scan. J. Immunol. 34:565-576.
Sandberg et al., 1990, J. Immunol. 145:1015-1020.
Sanhadji et al., 1997, AIDS 11:977-986.
Schneider et al., 1999, Lancet 353:201-203.
Shodell, M., FP Siegal: abstract submitted, FASEB AAI/CIS Congress, Seattle, WA, May, 2000.
Siegal et al., 1999, Science 284:1835-1837.
Siegel et al., 1994, Leukemia 8:1474-1479.
Siegal et al., 1986, J. Clin. Invest. 78:115-123.
Starr et al., 1993, Acv. Exp. Med. Biol. 329:173-178.
Sun et al., 1998, J. Exp. Med. 188:2335.
Svensson et al., 1996, J. Interferon Cytok. Res. 16:7-16.
Svensson et al., 1996, Scan. J. Immunol. 44:164-172.
Viellard et al., 1997, PNAS 94:11595-11600.

Affiliated with

Also associated with

Rating

Type I interferon-producing cells and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Type I interferon-producing cells and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Type I interferon-producing cells and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3823953